Family Medicine pp 1108-1115 | Cite as


  • Daniel T. Lee


Anemia, a common problem encountered by the family physician, is often fortuitously discovered. Anemia is a reduction of hemoglobin (Hgb) in the blood or hematocrit (Hct), which is the red blood cell (RBC) volume (Table 125.1). Similar to fever, anemia should be regarded as a sign of underlying disease. Furthermore, even though anemia is often seen in the elderly, it is not a consequence of advancing age.1 When anemia is detected, further evaluation is warranted.


Aplastic Anemia Mean Corpuscular Volume Folate Deficiency Reticulocyte Count Thymic Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Zauber NP, Zauber AG. Hematologic data of healthy very old people. JAMA 1987;257:2181–4.PubMedCrossRefGoogle Scholar
  2. 2.
    Rector WG. Pica: Its frequency and significance in patients with iron-deficiency anemia due to chronic gastrointestinal blood loss. J Gen Intern Med 1989;4:512–3.PubMedCrossRefGoogle Scholar
  3. 3.
    Bessman JD, Gilmer PR, Gardner, FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol 1983; 80:322–6.PubMedGoogle Scholar
  4. 4.
    Crosby WH. Reticulocyte counts. Arch Intern Med 1981; 141:1747–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Peter FM, editor. Trace elements—iron: recommended dietary allowances. Washington, DC: National Academy Press, 1989: 195–203.Google Scholar
  6. 6.
    Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron deficiency anemia. N Engl J Med 1993;329:1691–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Moses PL, Smith RE. Endoscopic evaluation of iron deficiency anemia. Postgrad Med 1995;98:213–26.PubMedGoogle Scholar
  8. 8.
    Stewart JG, Ahlquist DA, McGill DB, Ilstrup DM, Schwartz S, Owen RA. Gastrointestinal blood loss and anemia in runners. Ann Intern Med 1984;100:843–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Guyatt GH, Oxman AD, Ali M, Willan A, Mcllroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 1992;7:145–53.PubMedCrossRefGoogle Scholar
  10. 10.
    Olin BR, editor-in-chief. Blood modifiers: drug facts and comparisons. St. Louis: Kluwer, 1996:240–5.Google Scholar
  11. 11.
    Brise H. Influence of meals on iron absorption in oral iron therapy. Acta Med Scand 1962;171:39–45.CrossRefGoogle Scholar
  12. 12.
    Craig WJ. Iron status of vegetarians. Am J Clin Nutr 1994; 59:1233S-7S.PubMedGoogle Scholar
  13. 13.
    Beutler E. The common anemias. JAMA 1988;259:2433–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Cazzola M, Barosi G, Gobbi PG, Invernizzi R, Riccardi A, Ascari E. Natural history of idiopathic sideroblastic anemia. Blood 1988;71:305–12.PubMedGoogle Scholar
  15. 15.
    Bottomley SS. Sideroblastic anaemia. Clin Haematol 1982; 11:389–409.PubMedGoogle Scholar
  16. 16.
    Horadam VW, Hutton JJ. Anemia of chronic disease: basic concepts and management. Geriatrics 1983;38:51–8.PubMedGoogle Scholar
  17. 17.
    Krantz SB. Pathogenesis and treatment of the anemia of chronic disease. Am J Med Sei 1994;307:353–9.CrossRefGoogle Scholar
  18. 18.
    Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989;321: 158–62.PubMedCrossRefGoogle Scholar
  19. 19.
    Erslev AJ. Erythropoietin. N Engl J Med 1991;324:1339–44.PubMedCrossRefGoogle Scholar
  20. 20.
    Hoagland HC. Myelodysplastic (preleukemia) syndromes: the bone marrow factory failure problem. Mayo Clin Proc 1995;70:673–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Pruthi RK, Tefferi A. Pernicious anemia revisited. Mayo Clin Proc 1994;69:144–50.PubMedCrossRefGoogle Scholar
  22. 22.
    Nickoloff E. Schilling test: physiologic basis for and use as a diagnostic test. Crit Rev Clin Lab Sei 1988;26:263–76.CrossRefGoogle Scholar
  23. 23.
    Scott JM, Weir DG. Drug-induced megaloblastic change. Clin Haematol 1980;9:587–606.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Daniel T. Lee

There are no affiliations available

Personalised recommendations